Loading
Latest filing published 07 Aug 2024 for Dr. Reddy's Laboratories Limited, €4.9M.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Erez Israeli discloses dealings in Dr. Reddy's Laboratories Limited to SEBI (PIT + SAST). We count 7 filings; the first trade dates from 7 October 2022 and the latest from 7 August 2024.
Every open-market trade on record is a sale: 1 sale worth €300k. Besides market trades, the filings include 5 share grants.
After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +0.4%. This is a record of the past, not a forecast.
On 7 August 2024 came the latest disclosure, a share grant for €4.9M in Dr. Reddy's Laboratories Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations